Table 4.
Enzyme levels after the administration of amikacin and buprenorphine by manually and by AID.
S.No | Parameter | Amikacin | Buprenorphine | ||||||
---|---|---|---|---|---|---|---|---|---|
Manual | AID | Manual | AID | ||||||
Before | After | Before | After | Before | After | Before | After | ||
1 | AST (IU/L) | 39.83 ± 3.52 | 36.33 ± 9.59 | 43.83 ± 4.97 | 53.50 ± 10.23 | 42.17 ± 4.36 | 41.33 ± 3.73 | 40.52 ± 7.09 | 59.67 ± 10.84 |
F = 0.314; p = 0.588 | F = 1.584; p = 0.237 | ||||||||
2 | ALT (IU/L) | 44.50 ± 4.14 | 41.50 ± 4.47 | 32.22 ± 2.76 | 48.50 ± 5.65a | 47.07 ± 3.88 | 47.17 ± 3.95 | 31.40 ± 7.50 | 52.50 ± 5.70 |
F = 5.605; p = 0.039 | F = 2.431; p = 0.150 | ||||||||
3 | ALP (IU/L) | 59.30 ± 3.83 | 56.05 ± 7.76 | 65.52 ± 3.27 | 61.85 ± 10.98 | 54.08 ± 3.03 | 42.17 ± 4.79 | 59.28 ± 3.53 | 40.62 ± 5.96a |
F = 0.241; p = 0.634 | F = 7.019; p = 0.024 | ||||||||
4 | GGT (IU/L) | 8.70 ± 0.92 | 8.17 ± 0.60 | 7.58 ± 0.88 | 7.32 ± 0.37 | 8.78 ± 1.01 | 8.82 ± 0.45 | 6.98 ± 1.24 | 7.48 ± 0.50 |
F = 0.389; p = 0.547 | F = 0.105; p = 0.752 |
Mean ± SE (n = 6 each).
Significantly different from the respective before administration.
AID, autoinjector device; SE, standard error.